GoodRx Holdings, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
GoodRx Holdings, Inc. (GDRX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $1.72 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-26
- GoodRx Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $1.72M, a 75.39% decline from fiscal 2024.
- GoodRx Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $7.00M, a 34.24% decline from fiscal 2023.
- GoodRx Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $10.64M, a 2678.33% increase from fiscal 2022.
- GoodRx Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $383.00K, a 22.00% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.72M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $7.00M 10-K · filed 2026-02-26 | $105.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $10.64M 10-K · filed 2026-02-26 | $217.00K 10-K · filed 2024-02-29 |
| 2022-12-31 | $383.00K 10-K · filed 2025-02-27 | |
| 2021-12-31 | $491.00K 10-K · filed 2024-02-29 | |
| 2020-12-31 | $609.00K 10-K · filed 2023-03-01 | |
| 2019-12-31 | $313.00K 10-K · filed 2022-03-01 | |
| 2018-12-31 | -$99.00K 10-K · filed 2021-03-12 |